Injectable solid hyaluronic acid carriers for delivery of...

Details Injectable solid hyaluronic acid carriers for delivery of... Injectable solid hyaluronic acid carriers for delivery of...

2011-01-25

2011-01-25

Kosar, Andrew D (Department: 1654)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

C424S426000

Reexamination Certificate

active

07875590

ABSTRACT:
Methods of using an injectable or implantable rod-shaped formulation for delivery of osteogenic proteins to treat osteoporotic and/or osteopenic bone are disclosed. The formulation comprises hyaluronic acid derivatives and osteogenic proteins, and optional excipients and active ingredients such as a bone resorption inhibitor.

REFERENCES:
patent: 3955719 (1976-05-01), Pheulpin
patent: 4784055 (1988-11-01), Langen et al.
patent: 4851521 (1989-07-01), della Valle et al.
patent: 4957744 (1990-09-01), della Valle et al.
patent: 5118667 (1992-06-01), Adams et al.
patent: 5124316 (1992-06-01), Antoniades et al.
patent: 5308889 (1994-05-01), Rhee et al.
patent: 5336767 (1994-08-01), della Valle et al.
patent: 5352715 (1994-10-01), Wallace et al.
patent: 5356629 (1994-10-01), Sander et al.
patent: 5464440 (1995-11-01), Johansson
patent: 5510121 (1996-04-01), Rhee et al.
patent: 5645592 (1997-07-01), Nicolais et al.
patent: 5716413 (1998-02-01), Walter et al.
patent: 5752974 (1998-05-01), Rhee et al.
patent: 5939323 (1999-08-01), Valentini et al.
patent: 5942499 (1999-08-01), Radomsky
patent: 6015801 (2000-01-01), Daifotis et al.
patent: 6187742 (2001-02-01), Wozney et al.
patent: 6221958 (2001-04-01), Shalaby et al.
patent: 6281195 (2001-08-01), Rueger et al.
patent: 6699471 (2004-03-01), Radice et al.
patent: 7189392 (2007-03-01), Kim et al.
patent: 283073 (1997-12-01), None
patent: 2000-202024 (2000-07-01), None
patent: WO 91/17777 (1991-11-01), None
patent: WO 93/20858 (1993-10-01), None
patent: WO 97/32591 (1997-09-01), None
patent: WO 97/45532 (1997-12-01), None
patent: WO 97/49412 (1997-12-01), None
patent: WO 99/24070 (1999-05-01), None
patent: WO 00/16818 (2000-03-01), None
patent: WO 00/37124 (2000-06-01), None
patent: WO 01/28602 (2001-04-01), None
K.P. Vercruysse and G.D. Prestwich. Hyaluronate Derivatives in Drug Delivery, Critical Review in Therapeutic Drug Carrier Systems. (1998) 15(5), pp. 513-555.
N.H. Bell and R.H. Johnson. Bisphosphonates in the Treatment of Osteoporosis. Endochrine. (1997) 6(2), pp. 203-206.
U.S. Appl. No. 10/525,441, filed Feb. 22, 2005, Li et al., co-pending application.
U.S. Appl. No. 10/937,364, filed Sep. 10, 2004, Li et al., co-pending application.
Aigner et al., “Cartilage Tissue Engineering with Novel Nonwoven Structured Biomaterial Based on Hyaluronic Acid Benzyl Ester”,J Biomed Mater Res42:172-181 (1988).
Bonucci et al., “Prevention of Ovariectomy Osteopenia in Rats after Vaginal Administration of Hyaff 11 Microspheres Containing Salmon Calcitonin”,Calcif Tissue Int56:274-279 (1995).
Brun et al., “Chondrocyte Aggregation and Reorganization into Three-Dimensional Scaffolds”,J Biomed Mat Res46:337-46 (1999).
Campoccia et al., “Semisynthetic Resorbable Materials from Hyaluronan Esterification”,Biomaterials, 19:2101-27 (1998).
Common Organic Solvents: Table of Properties, www.organicdivision.org/organic—solvents.html (Oct. 20, 2007).
Fleisch, Bisphosphonates in bone disease, From the Laboratory to the patient, 3rd Ed. Parthenon Publishing (1997).
Ghezzo et al., “Hyaluronane Derivative Microspheres as NGF Delivery Devices: Preparation Methods and In Vitro Release Characterization”,Int J Pharmaceutics87:21-29 (1992).
Illum et al., “Hyaluronic Acid Ester Microspheres as a Nasal Delivery System for Insulin”,J Controlled Release29(1-2):133-141 (1994).
International Preliminary Examination Report for PCT/US2003/014609, dated Apr. 13, 2005.
International Search Report for PCT/US2003/014609, dated Apr. 9, 2004.
Kubler et al., “Bone Morphogenetic Protein-Mediated Interaction of Periosteum and Diaphysis”,Clin Osteoped Rel Res258:279-94 (1990).
Solchaga et al., “Hyaluronic Acid-Based Polymers as Cell Carriers or Tissue-Engineered Repair of Bone and Cartilage”,J Orthopaedic Res17:205-213 (1999).
Supplementary European Search Report, EP 03 72 6735.8, dated Sep. 5, 2007.

Affiliated with

Also associated with

Rating

Injectable solid hyaluronic acid carriers for delivery of... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Injectable solid hyaluronic acid carriers for delivery of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Injectable solid hyaluronic acid carriers for delivery of... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2689718